Augments Pfizer’s efforts to advance investigational medicines for cardiometabolic diseasesNEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global ...

POTOMAC, MARYLAND / ACCESS Newswire / December 9, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) ...

SIOUX FALLS, SD / ACCESS Newswire / December 9, 2025 / When a medical emergency happens in rural America, distance, staffing shortages, and fragmented communication can stand between a patient and ...

Nearly one in four European pharmaceutical companies remains vulnerable to regulatory risks due to inadequate quality systems ...

OPEN Health is pleased to announce that Diala Habib, PhD — an MM&M 40 under 40 honoree — has been appointed President of two of its practices, Promotional Medical Education and Patient Engagement.

Cohorts 1-3 remain free of cytokine release syndromeCRIS-7-derived CD3 design underpins a controlled T-cell response, supporting the differentiated safety profile, combinability with standard of care ...

COLUMBIA, MARYLAND / ACCESS Newswire / December 9, 2025 / Vheda Health has been awarded a Top Workplaces 2025 honor by Baltimore Sun Top Workplaces 2025. This list is based solely on employee feedback ...

Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.

Response Biomedical Corp. has been transforming acute care diagnostic testing globally, with the central focus on improving patient outcomes and healthcare reform for over 20 years. We have a platform ...

SAN FRANCISCO, CA / ACCESS Newswire / December 9, 2025 / Longwood Healthcare Leaders will convene top biopharmaceutical leaders at San Francisco CEO for two days of discussion, January 10-11, 2026, ...

LUND, SE / ACCESS Newswire / December 9, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX)(STO:ATORX) today comments on the announcement by Shanghai Henlius Biotech, Inc. that applications for ...

Therapy First Long-Lasting Osteoarthritis Treatment to Target All Four Major Disease EffectsFirst-Ever Use of Donor Gum Cells to Treat Osteoarthritis in HumansPARIS--(BUSINESS ...